FRM
CO

Fox Run Management’s Global Cord Blood Corporation CO Stock Holding History

Fox Run Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,640
Closed -$160K – 1049
2018
Q1 		$160K Buy
+15,640
New +$160K 0.04% 653

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SAM
Silphium Asset Management London, United Kingdom $264M AUM 19.59% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Fox Run Management's CO Position: Q2 2018 in Review

Fox Run Management sold out of Global Cord Blood Corporation (CO) in Q2 2018, closing a stake of 15,640 shares — an estimated $160K sold.

Fox Run Management first reported a position in CO in Q1 2018 and held it in 1 quarter. The position peaked at $160K in Q1 2018. 46 funds tracked by Wall St. Rank hold CO as of Q2 2018.

  • Fox Run Management reported no remaining Global Cord Blood Corporation position as of Q2 2018 after selling out during the quarter.
  • Fox Run Management sold 15,640 Global Cord Blood Corporation shares in Q2 2018, an estimated $160K.
  • Fox Run Management first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 1 quarter.
  • Fox Run Management's Global Cord Blood Corporation position peaked at $160K in Q1 2018.
  • 46 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2018.

Based on Fox Run Management's 13F filing for Q2 2018, filed 17 Jul 2018.